Haemonetics Corp (HAE)

77.18 +1.74 (+2.31%) USD  |  NYSE  |  Dec 23, 16:00
76.90 -0.28 (-0.36%) Pre-Market: 09:15
More

Haemonetics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for HAE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Boston Scientific Corp Upgrade
ResMed Inc Upgrade
Globus Medical Inc Upgrade
Baxter International Inc Upgrade
Abbott Laboratories Upgrade